AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2025
Feb 7, 2025
35200_dirs_2025-02-07_3da5c2b0-0af7-40d1-956b-c6757efe3ac2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2025-02-05
Reporting Person: McCall Patrick (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-05 | Employee Stock Option (right to buy) | $0.29 | A | 343000 | Acquired | 2035-02-05 | Common Stock (343000) | Direct |
Footnotes
F1: Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.